Transaction · 0001437749-26-000431

JORDEN DAVID EMERSON

JORDEN DAVID EMERSON, CEO, CFO, reported a transaction classified as exercise at Nuo Therapeutics, Inc. involving 125000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 0.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MCEO, CFO
AURXNuo Therapeutics, Inc.
Filing timeJan 06
Trade dateDec 31, 2018
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

AURX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
AURX since 2026-01-06Filed 240 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001437749-26-000431
Option to purchase common stock
Transaction date
Dec 31, 2018
Filed Jan 06, 2026, 12:25 AM · 2563d delay
Shares
125k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
0 sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 2563 calendar days after the transaction date.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Delayed Filing Derivative Transaction Direct Ownership
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO/CFO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Represents a net exercise of outstanding stock options. The reporting person received 99,619 shares of common stock on the net exercise of option to purchase 125,000 shares of common stock. The issuer…

Original filing · 0001437749-26-000431
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

AURX